New hope for hard-to-treat myeloma: triple drug combo enters phase 2 trial
NCT ID NCT07096778
First seen Feb 06, 2026 · Last updated Apr 29, 2026 · Updated 14 times
Summary
This study tests a new drug called inobrodib combined with two standard medicines (pomalidomide and dexamethasone) in 100 adults whose multiple myeloma has come back or no longer responds to available therapies. The goal is to see how well the combination shrinks tumors and to learn more about its side effects. Participants will know they are receiving the experimental treatment, and the study is not comparing it to any other therapy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA REFRACTORY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Oncology Partners, PA
RECRUITINGBethesda, Maryland, 20817, United States
-
Barts Health NHS Trust
RECRUITINGLondon, EC1A 7BE, United Kingdom
-
Imperial College Healthcare NHS Trust, Hammersmith Hospital
RECRUITINGLondon, W12 0HS, United Kingdom
-
King's College Hospital NHS Foundation Trust
RECRUITINGLondon, SE5 9RS, United Kingdom
-
Royal Marsden NHS Foundation Trust
RECRUITINGSutton, London, SM2 5PT, United Kingdom
-
The Christie NHS Foundation Trust
RECRUITINGWithington, Greater Manchester, M20 4BX, United Kingdom
-
The Clatterbridge Cancer Centre NHS Foundation Trust
RECRUITINGBebington, Wirral, CH63 4JY, United Kingdom
-
University of Nebraska Medical Center
RECRUITINGOmaha, Nebraska, 68198, United States
-
University of Pennsylvania, Abramson Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19104, United States
-
Western General Hospital
RECRUITINGEdinburgh, EH4 2XU, United Kingdom
-
Winship Cancer Institute
RECRUITINGAtlanta, Georgia, 30322, United States
Conditions
Explore the condition pages connected to this study.